(Q49064489)
Statements
1 reference
We should not distinguish between symptomatic and disease-modifying treatments in Alzheimer's disease drug development. (English)
1 reference
Rachelle S Doody
1 reference
21 December 2007
1 reference
4
1 reference
1 Suppl 1
1 reference
S21-5
1 reference